Voltaren Gel approved for OA
The U.S Food and Drug Administration has approved Voltaren Gel to
treat osteoarthritis (OA), making it the first topical treatment
for OA. In clinical trials, the non-steroidal anti-inflammatory gel
reduced patients' knee and hand pain by 51 percent.
Read full story >
See all Rheumatoid Arthritis News













